Regulation of bone metabolism by Wnt signals

Journal of Biochemistry

Volumn 159, Issue 4, 2016, Pages 387-392

  Kobayashi, Yasuhiro ^a   Uehara, Shunsuke ^a   Udagawa, Nobuyuki ^a   Takahashi, Naoyuki ^a  

^a MATSUMOTO DENTAL UNIVERSITY   (Japan)

Author keywords

bone; osteoblast; osteoclast; Wnt5a; Wntless

Indexed keywords

BETA CATENIN; FRIZZLED PROTEIN; LOW DENSITY LIPOPROTEIN RECEPTOR RELATED PROTEIN 5; MESSENGER RNA; OSTEOCALCIN; OSTEOPROTEGERIN; PARATHYROID HORMONE RECEPTOR 1; SCLEROSTIN; STRESS ACTIVATED PROTEIN KINASE; TRANSCRIPTION FACTOR OSTERIX; WNT PROTEIN; WNT3A PROTEIN; TNFRSF11B PROTEIN, HUMAN; TRANSCRIPTION FACTOR;

ARTICLE; BONE MASS; BONE METABOLISM; CARTILAGE CELL; HUMAN; NONHUMAN; OSTEOBLAST; OSTEOCLAST; OSTEOCLASTOGENESIS; OSTEOCYTE; OSTEOLYSIS; PROTEIN EXPRESSION; WNT SIGNALING PATHWAY; ANIMAL; BONE DEVELOPMENT; CELL DIFFERENTIATION; GENETICS; METABOLISM; MOUSE; MUTATION; PHYSIOLOGY; PROTEIN TRANSPORT;

ANIMALS; BETA CATENIN; BONE RESORPTION; CELL DIFFERENTIATION; HUMANS; LOW DENSITY LIPOPROTEIN RECEPTOR-RELATED PROTEIN-5; MICE; MUTATION; OSTEOBLASTS; OSTEOCLASTS; OSTEOGENESIS; OSTEOPROTEGERIN; PROTEIN TRANSPORT; TRANSCRIPTION FACTORS; WNT PROTEINS; WNT SIGNALING PATHWAY;

EID: 84964345760     PISSN: 0021924X     EISSN: 17562651     Source Type: Journal    
DOI: 10.1093/jb/mvv124     Document Type: Article

References (45)

1. Suda, T., Takahashi, N., Udagawa, N., Jimi, E., Gillespie, M.T., Martin, T.J. (1999) Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr. Rev. 20, 345-357
2. Takahashi, N., Akatsu, T., Udagawa, N., Sasaki, T., Yamaguchi, A., Moseley, J.M., Martin, T.J., Suda, T. (1988) Osteoblastic cells are involved in osteoclast formation. Endocrinology 123, 2600-2602
3. Nakashima, T., Hayashi, M., Fukunaga, T., Kurata, K., Oh-Hora, M., Feng, J.Q., Bonewald, L.F., Kodama, T., Wutz, A., Wagner, E.F., Penninger, J.M., Takayanagi, H. (2011) Evidence for osteocyte regulation of bone homeostasis through RANKL expression. Nat. Med. 17, 1231-1234
4. Xiong, J., Onal, M., Jilka, R.L., Weinstein, R.S., Manolagas, S.C., O'Brien, C.A. (2011) Matrixembedded cells control osteoclast formation. Nat. Med. 17, 1235-1241
5. Karsenty, G., Wagner, E.F. (2002) Reaching a genetic and molecular understanding of skeletal development. Dev. Cell 2, 389-406
6. Takayanagi, H., Kim, S., Koga, T., Nishina, H., Isshiki, M., Yoshida, H., Saiura, A., Isobe, M., Yokochi, T., Inoue, J., Wagner, E.F., Mak, T.W., Kodama, T., Taniguchi, T. (2002) Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev. Cell 3, 889-901
7. Yagi, M., Miyamoto, T., Sawatani, Y., Iwamoto, K., Hosogane, N., Fujita, N., Morita, K., Ninomiya, K., Suzuki, T., Miyamoto, K., Oike, Y., Takeya, M., Toyama, Y., Suda, T. (2005) DC-STAMP is essential for cell-cell fusion in osteoclasts and foreign body giant cells. J. Exp. Med. 202, 345-351
8. Kukita, T., Wada, N., Kukita, A., Kakimoto, T., Sandra, F., Toh, K., Nagata, K., Iijima, T., Horiuchi, M., Matsusaki, H., Hieshima, K., Yoshie, O., Nomiyama, H. (2004) RANKL-induced DC-STAMP is essential for osteoclastogenesis. J. Exp. Med. 200, 941-946
9. Simonet, W.S., Lacey, D.L., Dunstan, C.R., Kelley, M., Chang, M.S., Luthy, R., Nguyen, H.Q., Wooden, S., Bennett, L., Boone, T., Shimamoto, G., Derose, M., Elliott, R., Colombero, A., Tan, H.L., Trail, G., Sullivan, J., Davy, E., Bucay, N., Renshaw-Gegg, L., Hughes, T.M., Hill, D., Pattison, W., Campbell, P., Sander, S., Van, G., Tarpley, J., Derby, P., Lee, R., Boyle, W.J. (1997) Osteoprotegerin: a novel secreted protein involved in the regulation of bone density. Cell 89, 309-319
10. Gong, Y., Slee, R.B., Fukai, N., Rawadi, G., Roman-Roman, S., Reginato, A.M., Wang, H., Cundy, T., Glorieux, F.H., Lev, D., Zacharin, M., Oexle, K., Marcelino, J., Suwairi, W., Heeger, S., Sabatakos, G., Apte, S., Adkins, W.N., Allgrove, J., Arslan-Kirchner, M., Batch, J.A., Beighton, P., Black, G.C., Boles, R.G., Boon, L.M., Borrone, C., Brunner, H.G., Carle, G.F., Dallapiccola, B., De Paepe, A., Floege, B., Halfhide, M.L., Hall, B., Hennekam, R.C., Hirose, T., Jans, A., Juppner, H., Kim, C.A., Keppler-Noreuil, K., Kohlschuetter, A., Lacombe, D., Lambert, M., Lemyre, E., Letteboer, T., Peltonen, L., Ramesar, R.S., Romanengo, M., Somer, H., Steichen-Gersdorf, E., Steinmann, B., Sullivan, B., Superti-Furga, A., Swoboda, W., Van Den Boogaard, M.J., Van Hul, W., Vikkula, M., Votruba, M., Zabel, B., Garcia, T., Baron, R., Olsen, B.R., Warman, M.L. (2001) LDL receptor-related protein 5 (LRP5) affects bone accrual and eye development. Cell 107, 513-523
11. Baron, R., Kneissel, M. (2013) WNT signaling in bone homeostasis and disease: from human mutations to treatments. Nat. Med. 19, 179-192
12. Canalis, E. (2013) Wnt signalling in osteoporosis: mechanisms and novel therapeutic approaches. Nat. Rev. Endocrinol. 9, 575-583
13. Hill, T.P., Spater, D., Taketo, M.M., Birchmeier, W., Hartmann, C. (2005) Canonical Wnt/beta-catenin signaling prevents osteoblasts from differentiating into chondrocytes. Dev. Cell. 8, 727-738
14. Day, T.F., Guo, X., Garrett-Beal, L., Yang, Y. (2005) Wnt/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis. Dev. Cell 8, 739-750
15. Miller, J.R. (2002) The Wnts. Genome Biol. 3, reviews3001
16. Kim, J.B., Leucht, P., Lam, K., Luppen, C., Ten Berge, D., Nusse, R., Helms, J.A. (2007) Bone regeneration is regulated by wnt signaling. J. Bone Miner. Res. 22, 1913-1923
17. Bartscherer, K., Pelte, N., Ingelfinger, D., Boutros, M. (2006) Secretion of Wnt ligands requires Evi, a conserved transmembrane protein. Cell 125, 523-533
18. Banziger, C., Soldini, D., Schutt, C., Zipperlen, P., Hausmann, G., Basler, K. (2006) Wntless, a conserved membrane protein dedicated to the secretion of Wnt proteins from signaling cells. Cell 125, 509-522
19. Zhong, Z., Zylstra-Diegel, C.R., Schumacher, C.A., Baker, J.J., Carpenter, A.C., Rao, S., Yao, W., Guan, M., Helms, J.A., Lane, N.E., Lang, R.A., Williams, B.O. (2012) Wntless functions in mature osteoblasts to regulate bone mass. Proc. Natl. Acad. Sci. USA. 109, E2197-2204
20. Glass, D.A. II, Bialek, P., Ahn, J.D., Starbuck, M., Patel, M.S., Clevers, H., Taketo, M.M., Long, F., Mcmahon, A.P., Lang, R.A., Karsenty, G. (2005) Canonical Wnt signaling in differentiated osteoblasts controls osteoclast differentiation. Dev. Cell 8, 751-764
21. Balemans, W., Ebeling, M., Patel, N., Van Hul, E., Olson, P., Dioszegi, M., Lacza, C., Wuyts, W., Van Den Ende, J., Willems, P., Paes-Alves, A.F., Hill, S., Bueno, M., Ramos, F.J., Tacconi, P., Dikkers, F.G., Stratakis, C., Lindpaintner, K., Vickery, B., Foernzler, D., Van Hul, W. (2001) Increased bone density in sclerosteosis is due to the deficiency of a novel secreted protein (SOST). Hum. Mol. Genet. 10, 537-543
22. Brunkow, M.E., Gardner, J.C., Van Ness, J., Paeper, B.W., Kovacevich, B.R., Proll, S., Skonier, J.E., Zhao, L., Sabo, P.J., Fu, Y., Alisch, R.S., Gillett, L., Colbert, T., Tacconi, P., Galas, D., Hamersma, H., Beighton, P., Mulligan, J. (2001) Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein. Am. J. Hum. Genet. 68, 577-589
23. Balemans, W., Patel, N., Ebeling, M., Van Hul, E., Wuyts, W., Lacza, C., Dioszegi, M., Dikkers, F.G., Hildering, P., Willems, P.J., Verheij, J.B., Lindpaintner, K., Vickery, B., Foernzler, D., Van Hul, W. (2002) Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease. J. Med. Genet. 39, 91-97
24. Kramer, I., Loots, G.G., Studer, A., Keller, H., Kneissel, M. (2010) Parathyroid hormone (PTH)-induced bone gain is blunted in SOST overexpressing and deficient mice. J. Bone Miner. Res. 25, 178-189
25. Van Bezooijen, R.L., Roelen, B.A., Visser, A., Van Der Wee-Pals, L., De Wilt, E., Karperien, M., Hamersma, H., Papapoulos, S.E., Ten Dijke, P., Lowik, C.W. (2004) Sclerostin is an osteocyte-expressed negative regulator of bone formation, but not a classical BMP antagonist. J. Exp. Med. 199, 805-814
26. Collette, N.M., Genetos, D.C., Economides, A.N., Xie, L., Shahnazari, M., Yao, W., Lane, N.E., Harland, R.M., Loots, G.G. (2012) Targeted deletion of Sost distal enhancer increases bone formation and bone mass. Proc. Natl. Acad. Sci. USA. 109, 14092-14097
27. Leupin, O., Kramer, I., Collette, N.M., Loots, G.G., Natt, F., Kneissel, M., Keller, H. (2007) Control of the SOST bone enhancer by PTH using MEF2 transcription factors. J. Bone Miner. Res. 22, 1957-1967
28. Keller, H., Kneissel, M. (2005) SOST is a target gene for PTH in bone. Bone 37, 148-158
29. O'Brien, C.A., Plotkin, L.I., Galli, C., Goellner, J.J., Gortazar, A.R., Allen, M.R., Robling, A.G., Bouxsein, M., Schipani, E., Turner, C.H., Jilka, R.L., Weinstein, R.S., Manolagas, S.C., Bellido, T. (2008) Control of bone mass and remodeling by PTH receptor signaling in osteocytes. PLoS One 3, e2942
30. Powell, W.F. Jr., Barry, K.J., Tulum, I., Kobayashi, T., Harris, S.E., Bringhurst, F.R., Pajevic, P.D. (2011) Targeted ablation of the PTH/PTHrP receptor in osteocytes impairs bone structure and homeostatic calcemic responses. J. Endocrinol. 209, 21-32
31. Leupin, O., Piters, E., Halleux, C., Hu, S., Kramer, I., Morvan, F., Bouwmeester, T., Schirle, M., Bueno-Lozano, M., Fuentes, F.J., Itin, P.H., Boudin, E., De Freitas, F., Jennes, K., Brannetti, B., Charara, N., Ebersbach, H., Geisse, S., Lu, C.X., Bauer, A., Van Hul, W., Kneissel, M. (2011) Bone overgrowth-associated mutations in the LRP4 gene impair sclerostin facilitator function. J. Biol. Chem. 286, 19489-19500
32. Chang, M.K., Kramer, I., Huber, T., Kinzel, B., Guth-Gundel, S., Leupin, O., Kneissel, M. (2014) Disruption of Lrp4 function by genetic deletion or pharmacological blockade increases bone mass and serum sclerostin levels. Proc. Natl. Acad. Sci. USA. 111, E5187-5195
33. Xiong, L., Jung, J.U., Wu, H., Xia, W.F., Pan, J.X., Shen, C., Mei, L., Xiong, W.C. (2015) Lrp4 in osteoblasts suppresses bone formation and promotes osteoclastogenesis and bone resorption. Proc. Natl. Acad. Sci. USA. 112, 3487-3492
34. Maeda, K., Kobayashi, Y., Udagawa, N., Uehara, S., Ishihara, A., Mizoguchi, T., Kikuchi, Y., Takada, I., Kato, S., Kani, S., Nishita, M., Marumo, K., Martin, T.J., Minami, Y., Takahashi, N. (2012) Wnt5a-Ror2 signaling between osteoblast-lineage cells and osteoclast precursors enhances osteoclastogenesis. Nat. Med. 18, 405-412
35. Okamoto, M., Udagawa, N., Uehara, S., Maeda, K., Yamashita, T., Nakamichi, Y., Kato, H., Saito, N., Minami, Y., Takahashi, N., Kobayashi, Y. (2014) Noncanonical Wnt5a enhances Wnt/beta-catenin signaling during osteoblastogenesis. Sci. Rep. 4, 4493
36. Yamane, T., Kunisada, T., Tsukamoto, H., Yamazaki, H., Niwa, H., Takada, S., Hayashi, S.I. (2001) Wnt signaling regulates hemopoiesis through stromal cells. J. Immunol. 167, 765-772
37. Moverare-Skrtic, S., Henning, P., Liu, X., Nagano, K., Saito, H., Borjesson, A.E., Sjogren, K., Windahl, S.H., Farman, H., Kindlund, B., Engdahl, C., Koskela, A., Zhang, F.P., Eriksson, E.E., Zaman, F., Hammarstedt, A., Isaksson, H., Bally, M., Kassem, A., Lindholm, C., Sandberg, O., Aspenberg, P., Savendahl, L., Feng, J.Q., Tuckermann, J., Tuukkanen, J., Poutanen, M., Baron, R., Lerner, U.H., Gori, F., Ohlsson, C. (2014) Osteoblast-derived WNT16 represses osteoclastogenesis and prevents cortical bone fragility fractures. Nat. Med. 20, 1279-1288
38. Kobayashi, Y., Thirukonda, G.J., Nakamura, Y., Koide, M., Yamashita, T., Uehara, S., Kato, H., Udagawa, N., Takahashi, N. (2015) Wnt16 regulates osteoclast differentiation in conjunction with Wnt5a. Biochem. Biophys. Res. Commun. 463, 1278-1283
39. Dejmek, J., Safholm, A., Kamp Nielsen, C.,ersson, T., Leandersson, K. (2006) Wnt-5a/Ca2+induced NFAT activity is counteracted by Wnt-5a/Yes-Cdc42-casein kinase 1alpha signaling in human mammary epithelial cells. Mol. Cell. Biol. 26, 6024-6036
40. Oishi, I., Suzuki, H., Onishi, N., Takada, R., Kani, S., Ohkawara, B., Koshida, I., Suzuki, K., Yamada, G., Schwabe, G.C., Mundlos, S., Shibuya, H., Takada, S., Minami, Y. (2003) The receptor tyrosine kinase Ror2 is involved in non-canonical Wnt5a/JNK signalling pathway. Genes Cells 8, 645-654
41. Weeraratna, A.T., Jiang, Y., Hostetter, G., Rosenblatt, K., Duray, P., Bittner, M., Trent, J.M. (2002) Wnt5a signaling directly affects cell motility and invasion of metastatic melanoma. Cancer Cell 1, 279-288
42. Enomoto, M., Hayakawa, S., Itsukushima, S., Ren, D.Y., Matsuo, M., Tamada, K., Oneyama, C., Okada, M., Takumi, T., Nishita, M., Minami, Y. (2009) Autonomous regulation of osteosarcoma cell invasiveness by Wnt5a/Ror2 signaling. Oncogene 28, 3197-3208
43. Yu, B., Chang, J., Liu, Y., Li, J., Kevork, K., Al-Hezaimi, K., Graves, D.T., Park, N.H., Wang, C.Y. (2014) Wnt4 signaling prevents skeletal aging and inflammation by inhibiting nuclear factor-kappaB. Nat. Med. 20, 1009-1017
44. Chang, J., Sonoyama, W., Wang, Z., Jin, Q., Zhang, C., Krebsbach, P.H., Giannobile, W., Shi, S., Wang, C.Y. (2007) Noncanonical Wnt-4 signaling enhances bone regeneration of mesenchymal stem cells in craniofacial defects through activation of p38 MAPK. J. Biol. Chem. 282, 30938-30948
45. Sen, M., Lauterbach, K., El-Gabalawy, H., Firestein, G.S., Corr, M., Carson, D.A. (2000) Expression and function of wingless and frizzled homologs in rheumatoid arthritis. Proc. Natl. Acad. Sci. USA. 97, 2791-2796